FAZYX
Price
$14.57
Change
-$0.07 (-0.48%)
Updated
Nov 12 closing price
RLBEX
Price
$36.61
Change
-$0.22 (-0.60%)
Updated
Nov 12 closing price
Ad is loading...

FAZYX vs RLBEX

Header iconFAZYX vs RLBEX Comparison
Open Charts FAZYX vs RLBEXBanner chart's image
Fidelity Advisor Multi-Asset Income M
Price$14.57
Change-$0.07 (-0.48%)
VolumeN/A
CapitalizationN/A
American Funds American Balanced R4
Price$36.61
Change-$0.22 (-0.60%)
VolumeN/A
CapitalizationN/A
FAZYX vs RLBEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FAZYX vs. RLBEX commentary
Nov 13, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FAZYX is a StrongBuy and RLBEX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RLBEX has more cash in the bank: 241B vs. FAZYX (2.82B). FAZYX pays higher dividends than RLBEX: FAZYX (3.80) vs RLBEX (2.24). FAZYX was incepted earlier than RLBEX: FAZYX (9 years) vs RLBEX (22 years). FAZYX (175.00) and RLBEX (171.00) have comparable annual turnover. FAZYX has a lower initial minimum investment than RLBEX: FAZYX (0) vs RLBEX (250). RLBEX annual gain was more profitable for investors over the last year : 24.74 vs. FAZYX (19.70). FAZYX return over 5 years is better than : 52.90 vs. RLBEX (38.53).
FAZYXRLBEXFAZYX / RLBEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years22 years-
Gain YTD12.19315.73577%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets2.82B241B1%
Annual Yield % from dividends3.802.24170%
Returns for 1 year19.7024.7480%
Returns for 3 years7.4612.0762%
Returns for 5 years52.9038.53137%
Returns for 10 yearsN/A55.31-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BCS13.22-0.26
-1.93%
Barclays PLC
IPAR126.00-2.80
-2.17%
Interparfums Inc
KALA7.14-0.27
-3.58%
Kala BIO
KW11.10-0.60
-5.13%
Kennedy-Wilson Holdings
ALDX4.76-0.73
-13.30%
Aldeyra Therapeutics